ArgenTAG
Latest round
- Seed
Last raised
- Feb 2022
Total raised
- Undisclosed
Investors
- 1
About ArgenTAG
Based in New York, US, and founded in 2021, ArgenTAG Corporation operates as a biotech company that develops innovative genomic sequencing applications using proprietary technology. The company offers proprietary technology for long-read sequencing applications, including sequencing service, sequencing advisory, and sequencing kits.
Who invested in ArgenTAG
1 investor across 1 round
See all investors in ArgenTAG
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Feb 8, 2022
Amount
Undisclosed
Investors
Questions about ArgenTAG
Who invested in ArgenTAG?
ArgenTAG has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ArgenTAG raised?
ArgenTAG has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ArgenTAG last raise money?
ArgenTAG's most recent round on record is a Seed, in Feb 2022.
What does ArgenTAG do?
Based in New York, US, and founded in 2021, ArgenTAG Corporation operates as a biotech company that develops innovative genomic sequencing applications using proprietary technology.
Where is ArgenTAG headquartered?
ArgenTAG is headquartered in New York, US.
Which VCs invest in companies like ArgenTAG?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at ArgenTAG's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like ArgenTAG? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.